Skip to main content
Ken Zaslav, MD, Orthopaedic Surgery, New York, NY

KenZaslavMDProfessor Orthopedic Surgery(He/Him)

Orthopaedic Surgery New York, NY

Orthopedic Sports Medicine, Shoulder Surgery

Director Center for Regenerative Orthopedic Medicine

Dr. Zaslav is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Zaslav's full profile

Already have an account?

  • Office

    100 East 77th Street
    New York, NY 10075
    Phone+1 212-434-4324

Summary

  • Dr. Ken Zaslav is an orthopedic surgeon in New York, NY and is affiliated with Lenox Hill Hospital.

Education & Training

  • Stony Brook Medicine/University Hospital
    Stony Brook Medicine/University HospitalResidency, Orthopaedic Surgery, 1984 - 1988
  • Albert Einstein College of Medicine
    Albert Einstein College of MedicineClass of 1983

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1989 - Present
  • NY State Medical License
    NY State Medical License 1984 - 2025
  • VA State Medical License
    VA State Medical License 1990 - 2022
  • NC State Medical License
    NC State Medical License 1989 - 1999
  • Orthopaedic Surgery
    American Board of Orthopaedic Surgery Orthopaedic Surgery

Publications & Presentations

PubMed

Press Mentions

  • OrthoPreserve Receives Both FDA Breakthrough Device Designation and Prestigious TAP Enrollment for Meniscus Implant to Revolutionize Knee Pain Treatment
    OrthoPreserve Receives Both FDA Breakthrough Device Designation and Prestigious TAP Enrollment for Meniscus Implant to Revolutionize Knee Pain TreatmentJanuary 29th, 2025
  • Landmark Cartilage Repair Study: Agili-C Superior over Std of Care
    Landmark Cartilage Repair Study: Agili-C Superior over Std of CareAugust 5th, 2021
  • CartiHeal Announces Pivotal Study Results Demonstrate Agili-C™ Superiority to Microfracture and Debridement for the Treatment of Cartilage and Osteochondral Defects
    CartiHeal Announces Pivotal Study Results Demonstrate Agili-C™ Superiority to Microfracture and Debridement for the Treatment of Cartilage and Osteochondral DefectsAugust 3rd, 2021